Cargando…
Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?
Patients with a metabolic syndrome (overweight, diabetes, hypertension, and dyslipidemia) have a particularly bad outcome if infected with SARS-CoV-2. Yu et al. (2020) suggest that insulin therapy itself may promote fatality in patients with COVID-19 and diabetes.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685630/ https://www.ncbi.nlm.nih.gov/pubmed/33248018 http://dx.doi.org/10.1016/j.cmet.2020.11.015 |